10 mL blood sample Report in about 6 to 8 weeks Available at Mong Kok or Wan Chai centres
Whole genome sequencing is an advanced genetic testing technology that reads the entire genome and analyzes relevant hereditary information. Mutation data obtained from the test can be used for disease-related gene assessment and personalized medical planning.
Book Now
Since its establishment in 1997, Macrogen has become not only a leader in the genomics field in Korea, but also a leading company in the international market. Macrogen currently serves more than 18,000 research institutions across 153 countries worldwide and operates world-class analytical infrastructure, providing whole genome analysis services to more than 300,000 people each year. With these resources, the company advances big-data-driven precision medicine based on genomic information.
Macrogen, Inc. was founded in 1997 and is a listed Korean company (KOSDAQ: 038290).
The only Korean laboratory accredited by both FDA (CLIA) and the College of American Pathologists (CAP)
The CAP Laboratory Accreditation Program is internationally recognized as one of the most authoritative standards for laboratories.
Macrogen has published 13 papers in top academic journals including Nature, one of the world’s earliest and most prestigious scientific journals.
Next Generation Sequencing (NGS) is a method that divides the genome into multiple fragments, assembles the resulting sequence fragments, and analyzes the complete genomic sequence. Since 2000, NGS technology has developed rapidly and generated large volumes of genomic information for research. As the cost and turnaround time of genome analysis continue to fall, especially in medicine, NGS-based clinical research has become increasingly active. This is expected to accelerate precision medicine by enabling treatment plans optimized for each patient based on their genome.
Macrogen is a global leader in this field. Through NGS-based research and development and collaboration with medical institutions, it supports disease prediction and diagnosis and provides personalized treatment strategies based on genetic characteristics.
Learn more about Macrogen
6 mL blood sample | or saliva collection (clinic only) | US laboratory | about 3 to 4 weeks for report
Alpha and beta thalassemia / Fragile X syndrome / Developmental delay and autism / Deafness / Spinal muscular atrophy / Cystic fibrosis / Pompe disease
It helps you understand the risk of inherited genes that may cause certain diseases in your baby.
If neither you nor your partner is a carrier, your child is very unlikely to inherit the disease.
If one partner is a carrier but the other is not, your baby is very unlikely to inherit the disease.
If both you and your partner are carriers, your child has a 25% chance of inheriting the disease.
Although hereditary genetic testing can help you understand your health history and your chances of a healthy pregnancy and baby, it is not absolute.
...
Learn more
Book now
5 mL blood sample | US laboratory | about 2 to 4 weeks for report | available at Mong Kok or Wan Chai centres
Breast and gynecology (breast, ovary, uterus)
Gastrointestinal (colon, stomach, pancreas)
Endocrine (thyroid, parathyroid, pituitary)
Genitourinary (kidney/urinary tract, prostate)
Skin (melanoma, basal cell carcinoma)
Brain / nervous system
A positive result = a higher lifetime risk of cancer
Genetic testing can support treatment decisions
... Learn more
Book now
5 mL blood sample | about 2 to 4 weeks for report | available at Mong Kok or Wan Chai centres
According to Hospital Authority Cancer Registry data, Hong Kong recorded over 35,000 new cancer cases in 2019, with an average of 96 confirmed cases per day.
BRCA genes are associated with hereditary breast and ovarian cancer risk. BRCA1/2 mutations substantially increase the risk of breast and ovarian cancer.
What can BRCA testing tell you?
Book now
Current pre-pregnancy checkups often focus on fertility only. The bigger question is whether a couple may carry hereditary genes that could affect the child.
Planning for hereditary disease risk can be even more important.
...
Learn more
Book now
Saliva test | No food for 30 minutes | European laboratory | about 3 to 4 weeks for report
Rodinia is a screening test for gene variants associated with infertility. This test is suitable for...
Book now
3 mL blood sample | US laboratory | about 3 to 4 weeks for report | available at Mong Kok or Wan Chai centres
This panel analyzes genes associated with developmental delay, intellectual disability, autism, and related conditions. Combined with clinical findings, it can help doctors confirm diagnosis, assess prognosis and progression, support early symptom detection, and provide information for family planning and genetic counseling.
Suitable for
Book now
10 mL blood sample| about 6 to 8 weeks for report| available at Mong Kok or Wan Chai centres
Whole genome sequencing is an advanced genetic testing technology that reads the complete genome and analyzes related hereditary information. Mutation data can be used to evaluate disease-related genes and support personalized medical planning.
...
Learn more
Book now
10 mL blood sample| about 4 weeks for report| available at Mong Kok or Wan Chai centres| includes nutritionist consultation
Telomeres are an objective indicator of biological age. They play a critical role in cellular aging and are considered one of the key factors related to human longevity. Telomere research has also received Nobel-level recognition in health and longevity science.
...
Learn more
Book now